Nalaganje...
Combining Antivirals and Immunomodulators to Fight COVID-19
The majority of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected individuals remain paucisymptomatic, contrasting with a minority of infected individuals in danger of death. Here, we speculate that the robust disease resistance of most individuals is due to a swift production of...
Shranjeno v:
| izdano v: | Trends Immunol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier Ltd.
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7664349/ https://ncbi.nlm.nih.gov/pubmed/33281063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.it.2020.11.003 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|